Portal de Periódicos da CAPES

MER and Other Mycobacterial Fractions in the Immunotherapy of Cancer

1976; Elsevier BV; Volume: 60; Issue: 3 Linguagem: Inglês

10.1016/s0025-7125(16)31893-4

1557-9859

David Weiss,

Colorectal and Anal Carcinomas

Multidisciplinary efforts have defined a number of prognostic factors and newer strategies to improve the outcome of patients with breast cancer. Conservative surgery has led to improved functional and cosmetic results. The development of a number of effective adjuvant regimens has led to improved survival. In patients with stage I disease, several biological characteristics of tumor have been identified that are associated with increased risk of relapse. A multimodality approach to patients with locally advanced disease and inflammatory cancer has resulted in improved survival. A number of hormonal and cytotoxic drug contaminations can palliate metastatic disease, with a small fraction of patients remaining in extended remission. Dose-intensive programs may lead to further improvements in survival of selected patients with this disease.